UCL Technology Fund — Full Portfolio
28 tracked investments · listed companies and verified rows first
Meira GTx develops genetic medicine treatments for patients with devastating diseases, leveraging expertise in drug development and manufacturing.
BiotechDeep TechHealthtechMedical Devices
Alexandria Forbes(President and Chief Executive Officer and Director)Richard Giroux(Chief Operating Officer and Chief Financial Officer)Stuart Naylor(Chief Development Officer)Robert K. Zeldin(Chief Medical Officer)
Co-investorsAlbionVCOberland Capital
Echopoint Medical develops cardiac technology focused on coronary physiology for interventional cardiology.
Deep TechHardwareHealthtechMedical DevicesLondon, GB
Antony Odell(CEO & Co-Founder)inMalcolm Finlay(CMO & Co-Founder)inAdrien Desjardins(CSO & Co-Founder)inPriscila Hancock(Executive Officer)Nijs van de Vaart(COO)inPri Hancock(CFO)in
Co-investorsQueen Mary University of LondonAlbionVCParkwalk Advisors
AstronauTx is a biotechnology company focused on drug discovery and development for neurodegenerative and neuroinflammatory diseases, working across small molecules and biologics.
BiotechDeep TechHealthtechLongevityMedical Devices
Jane Rhodes(Chief Executive Officer)inMagnus Ivarsson(Chief Scientific Officer)inHannah Pearce(Chief Operating Officer)inMichelle L. Mellion(Chief Medical Officer)in
Co-investorsMPM BioImpactNovartis Venture FundSV Health InvestorsAlbionVC
Gigaton builds AI control systems for cement plants that continuously learn and adapt to optimize production while reducing costs and carbon emissions.
Advanced ManufacturingAI & Machine LearningCleantechClimate Tech
Co-investorsClean Growth FundSemapa Next
Intrinsic Semiconductor Technologies develops resistive random-access memory (RRAM) technology for non-volatile memory applications, enabling faster data access and write speeds with lower power consumption.
AI & Machine LearningDeep TechHardwareSemiconductorsLondon, GB
Dr Adnan Mehonic(Founder)Professor Tony Kenyon(Founder)Zack Deiri(President & CEO)
Co-investorsAlbionVCOctopus Ventures
Industrial augmented reality solution guiding and monitoring shopfloor workers.
Co-investorsArmilar Venture PartnersBlueCrow CapitalCriteria Venture TechRKKVC
Quell Therapeutics is a clinical-stage biopharmaceutical company developing targeted Treg cell therapies with advanced manufacturing capabilities.
BiotechDeep TechHealthtechMedical Devices
Co-investorsAlbionVCJeito CapitalSV Health Investors
Anon builds agentic AI solutions that deploy AI agents from prototypes to production systems for SMBs and Fortune 500 companies.
AI & Machine LearningDeveloper ToolsEnterprise Software
Co-investorsAbstract VenturesEx/AnteImpatient VenturesPicks and Shovels (Picks & Shovels)Spice CapitalUnion Square Ventures (USV)+2 more
A portfolio biopharmaceutical company that translates breakthroughs in biology and basic medical research from top universities into novel therapeutics.
BiotechHealthtechCambridge, GB
Co-investorsPatient Square CapitalRock Springs CapitalAlbionVC
EpilepsyGTx is a preclinical-stage biotech developing gene therapies for focal refractory epilepsy (FRE), with the aim of making patients seizure free.
BiotechDigital Health
Co-investorsAlbionVCMoonstone Venture CapitalXGEN VentureBritish Business Bank
Epsilogen develops antibody therapeutics based on the IgE, IgA, and IgG immunoglobulin isotypes for the treatment of cancer, matching each isotype to specific tumor types and combining isotypes into single antibody molecules.
BiotechHealthtech
Tim Wilson(Chief Executive Officer)Kevin FitzGerald(Chief Scientific Officer)inCristina Oliva(Chief Medical Officer)inNick Robbins-Cherry(Chief Financial Officer)inElizabeth Hardaker(Chief Translational Science Officer)
Co-investors3B Future Health FundAlbionVCEpidarex CapitalGlobal BioAccess FundNovartis Venture FundBioGeneration Ventures
Gaussion develops magnetic battery control technology that improves charging speed, heat generation, and lifetime performance across different cell formats and chemistries for electric vehicles, stationary storage, and industrial applications.
Deep TechEnergyHardwareLondon, GB
Tom Heenan(Founder)in
Co-investorsAutotech VenturesFuture VenturesAlbionVCDN Capital
Gigaton builds AI-powered control systems for energy-intensive industries to autonomously optimize operations and reduce costs and carbon emissions.
Advanced ManufacturingAI & Machine LearningCleantechClimate TechNew Materials
Co-investorsClean Growth FundSemapa NextAlbionVCPlanet A Ventures
Hazy provides a data-sharing platform with built-in GDPR-compliant legal agreements, access controls, and audit logs to help businesses share customer data responsibly.
AI & Machine LearningCybersecurityData & Infrastructure
Harry Keen(Founder)in
Co-investorsM12 (Microsoft's Venture Fund)Notion CapitalACT Venture PartnersConvictionConviction VCLogo Ventures+3 more
Humanloop was a development platform for building and managing large language model applications, providing tools for evaluating and managing AI systems.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US
Raza Habib(Founder)inJordan Burgess(Founder)inPeter Hayes(Founder)in
Co-investorsAlbionVCIndex VenturesY CombinatorEveningLocalGlobe
NovalGen is a clinical-stage biotechnology company developing multi-specific biologics for oncology, autoimmune, haematological, and metabolic disorders using its proprietary AutoRegulation platform technology.
BiotechHealthtechLongevityMedical DevicesLondon, GB
Co-investorsAlbionVC
Orchard Therapeutics develops ex vivo autologous hematopoietic stem cell (HSC) gene therapies for genetic and other severe diseases, including rare inherited conditions such as ADA-SCID and metachromatic leukodystrophy.
BiotechDeep TechHealthtechMedical DevicesLondon, GB
Donald Kohn(Scientific Founder)Adrian Thrasher(Scientific Founder)Frank E. Thomas(Executive Officer)inSteven M. Altschuler(Director)John Curnutte(Director)
BoardBobby Gaspar(Scientific Founder)in
Co-investorsAlbionVCF-Prime CapitalForesite CapitalAgent CapitalBaillie GiffordCowen Healthcare Investments+2 more
Oriole Networks develops PRISM, an all-optical circuit-switched networking fabric that uses photonic switching to connect GPUs at scale for AI/ML and high-performance computing data centers.
AI & Machine LearningDeep TechHardwareLondon, GB
George Zervas(Co-founder)inAlessandro Ottino(Co-founder)inJoshua Benjamin(Co-founder)inJames Regan(CEO)in
Co-investorsAlbionVCClean Growth FundPluralXTX Markets
Phasecraft develops quantum computing systems and software by combining quantum information theory, materials science, and engineering to advance practical quantum advantage.
AI & Machine LearningDeep TechQuantum Computing
Prof. Ashley Montanaro(Co-Founder & CEO)inProf. Toby Cubitt(Co-Founder, CTO & CSciO)inProf. John Morton(Co-Founder & Director)in
Co-investorsAlbionVCEpisode1Playground GlobalParkwalk AdvisorsPlural
Pometry provides a temporal graph database platform with AI infrastructure tools for querying and analyzing time-aware data across business, technical, and AI agent contexts.
AI & Machine LearningData & InfrastructureEnterprise Software
Alhamza Alnaimi(Founder)in
Co-investorsAlbionVCCambridge Angels groupCrane Venture Partners
Spur Therapeutics develops gene therapy treatments for genetic diseases, aiming to bring genetic medicine therapies to patients worldwide.
BiotechDigital HealthHealthtechMedical Devices
BoardChris(Chair (until August 2026), Chief Executive Officer)
Co-investorsAlbionVC
Stanhope AI develops a Free Energy Minimizing (FEM) world model, an AI architecture for autonomous machines that controls behavior, enables mission planning, and supports human-machine teaming.
AI & Machine LearningDeep TechRoboticsLondon, GB
Rosalyn Moran(Founder & CEO)in
BoardKarl Friston(Scientific Adviser)
Co-investorsAlbionVCAuxxoMMC VenturesMoonfire VenturesPaladin Capital GroupFrontline Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
0 6 Bramble Energy14 Glialign23 Odin Vision32 Third Space Learning
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.










.jpg)

















.jpeg)















.jpeg)


































